Verification evidence is still being completed.
Recipharm
Stockholm, Sweden
- Verified lead
- Greg Behar
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- CDMO Operations, Sterile Manufacturing, and Pharmaceutical Supply
- Review cycle
- May 2026
- Full address
- Klara Ostra Kyrkogata 6, 111 52 Stockholm, Sweden
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Recipharm leadership page confirming Greg Behar as CEO.
- Editorial note
- Recipharm extends the Swedish directory layer with a current executive record and a live global CDMO operating footprint.
CDMO Operations, Sterile Manufacturing, and Pharmaceutical Supply
GMP pharmaceutical manufacturing network, Quality and supply-chain operations
Recipharm extends the Swedish directory layer with a current executive record and a live global CDMO operating footprint.
Recipharm extends the Swedish directory layer with a current executive record and a live global CDMO operating footprint.
- Lead
- Greg Behar (verified ↗)
- Address
- Klara Ostra Kyrkogata 6, 111 52 Stockholm, Sweden (source ↗)
- Compliance
- GMP pharmaceutical manufacturing network
- Last reviewed
- 14 Mar 2026 (3mo ago)
- Scale
- International CDMO manufacturing
- Capabilities
- Sterile Manufacturing · Finished Dose Production · CDMO Supply Operations
- Founded
- 1995
- Headcount
- 5001-10000
- Company page (open ↗)
Greg Behar
Chief Executive Officer
Official Recipharm Stockholm city HQ page listing the visiting address at Klara Ostra Kyrkogata 6.
Open sourceInternational CDMO manufacturing
Stockholm, Sweden. CDMO Operations, Sterile Manufacturing, and Pharmaceutical Supply. Review completed on 14 Mar 2026.
EU and global pharmaceutical manufacturing oversight
GMP pharmaceutical manufacturing network, Quality and supply-chain operations
CDMO Operations, Sterile Manufacturing, and Pharmaceutical Supply
Recipharm extends the Swedish directory layer with a current executive record and a live global CDMO operating footprint.
Recipharm extends the Swedish directory layer with a current executive record and a live global CDMO operating footprint.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- VERIFIED ACTIVE 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is Recipharm located?
- Recipharm operates from Klara Ostra Kyrkogata 6, 111 52 Stockholm, Sweden, Stockholm, Sweden.
- Who runs Recipharm?
- Recipharm is led by Greg Behar, Chief Executive Officer. Verified 14 Mar 2026.
- What certifications does Recipharm hold?
- Recipharm is documented under GMP pharmaceutical manufacturing network.
- What does Recipharm do?
- Recipharm extends the Swedish directory layer with a current executive record and a live global CDMO operating footprint. Core capabilities: Sterile Manufacturing, Finished Dose Production, CDMO Supply Operations.
Related technical briefs
Briefs that name Stockholm as a covered market or city.
